75 Search Results

q=Lung

Search Again


Karen Syrjala , PhD

Email: ksyrjala@fredhutch.org

Phone: (206) 667-4579

Dr. Syrjala is Director of Behavioral Sciences and co-director of the Survivorship Program. Her focus is on helping people recognize their strengths and take charge of their health during treatment and long-term survival.

View Bio

Maria Tretiakova , MD, PhD

Email: mariast@uw.edu

Phone: (206) 897-4294

Dr. Tretiakova's clinical specialty is general surgical pathology with special emphasis on genitourinary pathology. Her main research interests are focused on prostate, kidney and bladder cancer biomarkers and novel therapeutic targets using tissue microarrays, immunohistochemistry, molecular pathology, and digital imaging. In addition to clinical and research activities, Dr. Tretiakova directs the Diagnostic Pathology clerkship and coordinates residents/fellows rotations at the Harborview Medical Center.

View Bio

Matthew Triplette , MD, MPH

Email: mtrip@uw.edu

Phone: (206) 667-6335

Dr. Triplette is a specialist in pulmonary and critical care medicine, and is an assistant professor in the Department of Medicine and an assistant member of the Clinical Research Division at the Fred Hutchinson Cancer Research Center. He sees patients in the outpatient setting at the Seattle Cancer Care Alliance, and provides consultative and critical care services to oncology inpatients at the UW. His research and clinical interests are in chronic lung disease in immunosuppressed patients, as well as lung cancer screening, and he is an active participant in the UW lung cancer screening program.

View Bio

Thomas Varghese Jr. , MD

Email: tkv@u.washington.edu

Phone: (206) 744-8744

Dr. Varghese's clinical interests are in benign and malignant disease of the lungs, esophagus, chest wall and mediastinum; thoracic trauma; and minimally invasive applications for general thoracic surgery. He is dedicated to the education of healthcare providers, patients, medical students, residents and fellows and is a core faculty member of the Institute of Simulation and Interprofessional Studies (ISIS). Dr. VargheseΓÇÖs research interests include methods to promote the uptake of research findings into healthcare (implementation science); educational interventions for patient-centered care; and surgical outcomes and quality of care research using population-based data, cost & utility analyses and patient-derived outcomes.

View Bio

Joshua Veatch , MD, PhD

Email: jveatch@fredhutch.org

Phone: (206) 667-5108

For Dr. Veatch, not only does he see patients in clinic at Seattle Cancer Care Alliance, but he is also involved in clinical research. He currently works with Dr. Stanley Riddell in the clinical research division at the Fred Hutch, working to develop new immune therapies to help patients with melanoma. In one project, they are developing a new type of cancer vaccine targeted at the mutations specific to a patient's cancer, in order to strengthen T-cell responses to fight the cancer.

View Bio

Trang VoPham , PhD, MPH, MS

Email: tvopham@fredhutch.org

Phone: (206) 667-2642

Dr. VoPham is an epidemiologist and geospatial scientist whose research focuses on understanding the role of place or location — particularly environmental exposures — in cancer. She integrates methods in cancer epidemiology, environmental epidemiology and geospatial science, including geographic information systems, or GIS, and remote sensing technologies, to study how environmental exposures might impact the risk of developing cancer. Her research includes epidemiologic studies examining the associations between particulate matter air pollution, dioxin, pesticides, radon, ultraviolet radiation, and circadian misalignment and the risk of liver, breast and lung cancer using data from the Nurses’ Health Studies; SEER; and SEER-Medicare. Dr. VoPham is also an expert in developing environmental exposure models using geospatial methods for exposure assessment in epidemiologic studies.

View Bio

Wei Wei , PhD

Email: wwei@systemsbiology.org

Phone: (206) 732-1221

The Wei group works in the highly cross-disciplinary field of BioMEMS, molecular and cellular analysis, and systems biomedicine. These joint efforts allow us to integrate single cell technologies with other biotechnological tools and computational approaches to investigate cutting-edge cancer biology questions with a balance between discovery and clinical translation. Specifically, we are interested in the following three areas: 1) Single-cell multi-omics tools and associated multivariate computational approaches for interrogating the heterogeneous tumor cells and immune cells at multiple bimolecular levels; 2) Epigenetic remodeling and signaling network dynamics associated with cell state transition and resistance development in epigenetically plastic tumors; 3) Liquid biopsy-based rare cell analysis for cancer metastasis and immunotherapy.

View Bio

Douglas Wood , MD

Email: dewood@u.washington.edu

Phone: (206) 685-3228

Dr. Wood specializes in thoracic oncology (lung, esophageal, mediastinal and chest wall tumors); benign and malignant airway disease; and emphysema surgery.

View Bio

Steven Zeliadt , PhD, MPH

Email: szeliadt@u.washington.edu

Phone: (206) 277-4175

Dr. Zeliadt's research interests include decision-making and quality of life in prostate cancer treatment, cancer screening, costs of health care interventions, evaluation of informed decision making strategies, comparative effectiveness using large databases, quality of life assessment among cancer survivors, decision modeling, assessment of health care costs.

View Bio

Jing Zeng , MD

Email: jzeng13@uw.edu

Phone: (206) 598-5998

Dr. Zeng is a radiation oncologist who specializes in treating lung cancer, thoracic malignancies, and genitourinary tumors, including prostate cancer, using the latest technologies and available clinical trials.

View Bio

Lue-Ping Zhao , PhD

Email: lzhao@fredhutch.org

Phone: (206) 667-6927

Being trained in biostatistics/bioinformatics, epidemiology and genetics, Dr. Zhao's current interest in STTR includes how to use omics methodology to dissect solid tumor etiology and mechanism with either expression arrays, SNP arrays, or short-read sequencing methods. Further, he is interested in utilizing large and complex electronic medical records with modern genomic technologies for translational bioinformatics studies.

View Bio

Steven Ziegler , PhD

Email: sziegler@benaroyaresearch.org

Phone: (206) 287-5657

The projects in Dr. Ziegler’s laboratory are focused on the factors that control normal immune regulation, as well as those that contribute to disease development and progression. The laboratory is currently engaged in two areas of investigation: the genes and cell populations that are involved in controlling autoimmune-type responses, and the role of epithelial cytokines (TSLP, IL-25, and IL-33) in the regulation of barrier responses to infection and allergen challenge. Finally, they have also found a novel role for TSLP in the regulation of tumor progression, and have established a program in tumor biology, including metastatic breast cancer, colitis-associated cancer and melanoma.

View Bio